CON earnings analysis
What we found in CON's 10-Q: the parts that mattered, the offsets in the same document, and what the company said about what comes next.
Our reading of the filing · Free to read, no account needed
Concentra Group Holdings Parent, Inc. reported a strong Q1 2026 with revenue of $569.6 million, exceeding estimates by 2.87%, and EPS of $0.40, surpassing expectations by 17.65%. This represents a 13.7% growth in revenue year-over-year, driven by increased patient visits and efficient operations.
The parts that mattered.
Pulled out of the filing itself, with the figures the company reported.
- Revenue Growth
- Revenue increased 13.7% from $500.8M in Q1 2025 to $569.6M in Q1 2026.
- EPS Surprise
- Reported EPS of $0.40 beat estimates of $0.34 by 17.65%.
- Improved Margins
- Gross margin improved to 29.9% from 28.7%, demonstrating better cost management.
- Higher Adjusted EBITDA
- Adjusted EBITDA rose to $120.7M, up from $102.7M, marking a 17.5% increase.
- Increased Patient Visits
- Total patient visits increased by 6.7%, reaching 3,419,091 in Q1 2026.
- Share Repurchase Program
- Repurchased $15M worth of shares during the quarter, with $65M remaining for future buybacks.
And the other side of it.
The offsets in the same document — the things a summary that only listed the good news would have left out.
- High Debt Levels
- Total debt remains high at $940.5M with significant interest expense of $26M.
- Regulatory Scrutiny
- The company faces risks from increased regulatory scrutiny impacting operations.
- Litigation Risks
- Ongoing litigation may expose the company to substantial liabilities, affecting future cash flows.
What they reported.
What the company itself reported, taken out of the document.
- Earnings per share
- $0.4
- Gross margin
- 29.9%
- Operating margin
- 16.8%
- Segment
- Occupational health centers: 91%
- Segment
- Onsite health clinics: 7%
- Segment
- Other businesses: 2%
What they said about what is next.
Management raised full-year revenue guidance to $2.275B-$2.375B and adjusted EBITDA to $460M-$480M.
The filing reads better than the one before it.
What came before.
- 10-K · February 26, 2026
- Concentra (CON) presents a strategy focused on scale in occupational health, expanding onsite clinic capability and telemedicine while pursuing M&A to grow reach. 2025 revenue was $2,163.4 million, driven primarily by…
- 10-Q · November 6, 2025
- Concentra reported Q3 revenue of $572,800 (in thousands) and GAAP diluted EPS of $0.38 for the three months ended September 30, 2025. Revenue rose year-over-year from $489,638 (in thousands) while gross margin remained…
This is our reading of a public filing, not the filing. Read the original on SEC.gov · Educational only. Nothing here is investment advice.
Read the next one first.
We read every filing CON makes the day it lands, and put it next to what the options market did about it. Members get both, and an alert when a filing arrives.
Cancel anytime · Month to month · Switch tiers whenever